There is no doubt that we live longer, that is, the world population is aging; partly thanks to advances in science and technology, and its application to medicine for the prevention, cure, and recovery of different nosological entities previously considered lethal. The world life expectancy in 1990 was 65.45 years; for the dawn of the new millennium, it increased to 67.68, for 2010 to 70.68 and for 2017 to 72.25 years of life at birth. In general terms, the world population of people over 50 almost doubled from 878 million in 1990 to 1,640 million in 2015. As is already known, the fact that the population is living longer brings with it the increase of so-called degenerative diseases, among which is age-related macular degeneration (AMD). We live longer, but we see less.

No hay duda que vivimos más, es decir, la población mundial está envejeciendo; en parte gracias a los avances en ciencia y tecnología, y su aplicación a la medicina para la prevención, curación y recuperación de las diferentes entidades nosológicas antes consideradas letales. La esperanza de vida mundial en 1990 era 65.45 años; para los albores del nuevo milenio incrementó a 67.68, para 2010 a 70.68 y para 2017 a 72.25 años de vida al nacer. En términos generales, la población mundial de personas mayores de 50 años casi se dobló de 878 millones en 1990 a 1640 millones en 2015. Como es ya conocido, el hecho que la población esté viviendo más, trae consigo el incremento de enfermedades llamadas degenerativas, entre las cuales se encuentra la degeneración macular relacionada a la edad (DMRE). Vivimos más, pero vemos menos.

Introduction. This article summarizes the clinical practice guidelines (CPG) for the diagnosis and treatment of diabetic retinopathy and diabetic macular edema of the Health Social Security of Peru (EsSalud). Objective. To provide clinical recommendations based on evidence for the diagnosis and treatment of diabetic retinopathy and diabetic macular edema in EsSalud. Methods. A guidelines elaborating group (GEG) was conformed by medical specialists and methodologists. The GEG formulated 4 clinical questions intended to be answered by this CPG. For each of these questions systematic searches of systematic reviews and primary studies (when considered pertinent) were carried out in PubMed during 2018. Evidence was selected in order to reply each of the proposed clinical questions. The certainty of the evidence was evaluated using the Grading of Recommendati...